About pcm

Manuscript Submission

AME Editing Service

Reprint & Permission

Advertising

Contact us

Editorial Commentary 
Checkpoint inhibitors first in patients with metastatic non-small cell lung cancer harboring BRAFV600E mutation with PD-L1 90%—a debate in a niche population
Yusra F. Shao, Ammar Sukari, Misako Nagasaka
Precision Cancer Medicine  
2020;
3:
35  
Editorial Commentary 
CM227/CM9-LA: evidence supporting ipilimumab-based immunotherapy in the first-line treatment of metastatic NSCLC
Emily F. Collier, Sarah B. Goldberg
Precision Cancer Medicine  
2020;
3:
34  
Editorial Commentary 
ADAURA: a definitive answer to the wrong question
Howard West
Precision Cancer Medicine  
2020;
3:
32  
Letter to the Editor 
Utility of high-throughput sequencing of T-cell receptor rearrangements in assessing treatment response in patients with mature T-cell lymphoma
Pooja M. Phull, Carlyn R. Tan, Henry C. Fung, Paul A. Fields, Yang Liu, Jasmine Zain, Nathan H. Fowler, R. Katherine Alpaugh, Yasuhiro Oki, Stefan K. Barta
Precision Cancer Medicine  
2020;
3:
31  
Case Report 
Use of 3D-planning and tantalum in revision total hip arthroplasty after failed iliac bone allograft for Ewing sarcoma: a case report
Michele Fiore, Andrea Sambri, Riccardo Zucchini, Claudio Giannini, Fulvia Taddei, Massimiliano De Paolis
Precision Cancer Medicine  
2020;
3:
30  
Case Report 
Effective tyrosine kinase inhibitor re-treatment in epidermal growth factor receptor-mutated non-small-cell lung cancer patient: a case report
Alessandro Galletti, Marco Russano, Fabrizio Citarella, Bruno Vincenzi, Giuseppe Tonini, Daniele Santini
Precision Cancer Medicine  
2020;
3:
29  
Case Report 
Feasibility of ultra-central stereotactic ablative irradiation in lung cancer undergoing nivolumab: a case report
Valerio Nardone, Maria Grazia Calvanese, Maria Mormile, Francesca Maria Giugliano, Pierpaolo Correale, Alfonso Reginelli, Salvatore Cappabianca, Cesare Guida
Precision Cancer Medicine  
2020;
3:
28  
Case Report 
Micrometastatic breast cancer presenting as abnormal uterine bleeding: case report
Noah Gomez, Mark McNeely, Jaya Ruth Asirvatham, Ashwin S. Akki
Precision Cancer Medicine  
2020;
3:
27  
Review Article 
A narrative review of BRAF alterations in human tumors: diagnostic and predictive implications
Lynette M. Sholl
Precision Cancer Medicine  
2020;
3:
26  
Original Article 
Central nervous system progression and liquid biopsy in patients with oncogene addicted non-small cell lung cancer treated with ALK/ROS1 inhibitors
Mihaela Aldea, Damien Vasseur, Cristina Teixidó, Laura Mezquita
Precision Cancer Medicine  
2020;
3:
25  
Editorial 
On opposing ideas
Grace K. Dy
Precision Cancer Medicine  
2020;
3:
24  
Case Report 
“Lazarus effect” in patient affected by lung adenocarcinoma carrying EGFR, CTNNB1, MET exon 11 and PIK3CA mutations treated with gefitinib
Nicole Conci, Filippo G. Dall’Olio, Vittoria Comellini, Stefano Brocchi, Rita Golfieri, Andrea Ardizzoni
Precision Cancer Medicine  
2020;
3:
23  
Case Report: Precision Oncology Tumor Board 
Prolonged immune checkpoint inhibitor response of a patient with a RET rearranged non-small cell lung cancer and high tumour mutational burden: case report and review of the literature
Safiye Dursun, Tom E. J. Theunissen, Xiaofei Li, Ernst-Jan M. Speel, Lizza E. L. Hendriks
Precision Cancer Medicine  
2020;
3:
22  
Case Report: Precision Oncology Tumor Board 
Trastuzumab-Pertuzumab resistance in a case of HER2-del16 expressing colorectal cancer—a case report
Sayak Ghatak, Kevin Lin, Emil Lou, Andrew C. Nelson
Precision Cancer Medicine  
2020;
3:
21  
Review Article 
A narrative review of salvage therapy in small cell lung cancer
Saira Farid, Stephen V. Liu
Precision Cancer Medicine  
2020;
3:
20  
Review Article 
Prognostic impact of targetable genetic variants in resected adenocarcinoma of the lung: a narrative review and model proposal for precise evaluation
Masaoki Ito, Yoshihiro Miyata, Morihito Okada
Precision Cancer Medicine  
2020;
3:
19  
Editorial Commentary 
Current and future perspectives in lung cancer prevention
Adrián González-Marrón, Juan Carlos Martín-Sánchez, Jose M. Martínez-Sánchez
Precision Cancer Medicine  
2020;
3:
18  
Case Report: Precision Oncology Tumor Board 
Cases of ROS1-rearranged lung cancer: when to use crizotinib, entrectinib, lorlatinib, and beyond?
Kartik Sehgal, Andrew J. Piper-Vallillo, Hollis Viray, Adeel M. Khan, Deepa Rangachari, Daniel B. Costa
Precision Cancer Medicine  
2020;
3:
17  
Case Report 
Hepatic lymphoepithelioma-like carcinoma: a case report with literature review
Chunxiu Yang, Yueying Li, Yanyan Chen, Shu-Yuan Xiao
Precision Cancer Medicine  
2020;
3:
16  

Editorial

AR-V7 and treatment selection in advanced prostate cancer: are we there yet?
Diogo A. Bastos, Emmanuel S. Antonarakis

Case Report: Precision Oncology Tumor Board

Cases of ROS1-rearranged lung cancer: when to use crizotinib, entrectinib, lorlatinib, and beyond?
Kartik Sehgal, Andrew J. Piper-Vallillo, Hollis Viray, Adeel M. Khan, Deepa Rangachari, Daniel B. Costa